Not applicableStudy completedNCT05062135What this trial is testingProgesterone Action on Endometrium of PCOSWho this might be right forPolycystic OvaryProgesterone Resistance University of Sao Paulo General Hospital 36
Testing effectiveness (Phase 2)WithdrawnNCT04184323What this trial is testingSIRT-1 Antagonism for Endometrial ReceptivityWho this might be right forEndometriosisUterine DiseasesEndometrial Diseases+2 more Wake Forest University Health Sciences
Not applicableActive Not RecruitingNCT03756480What this trial is testingCancer Driving Mutations in Endometriosis Lesions and Development of Progesterone ResistanceWho this might be right forEndometriosisEndometrial Diseases Johns Hopkins University 135
Testing effectiveness (Phase 2)WithdrawnNCT03377101What this trial is testingFulvestrant and Palbociclib With or Without Copanlisib in Treating Patients With Hormone Receptor Positive, HER2 Negative, Stage IV Breast CancerWho this might be right forEstrogen Receptor PositiveHER2/Neu NegativeProgesterone Receptor Positive+1 more National Cancer Institute (NCI)
Early research (Phase 1)Looking for participantsNCT06586957What this trial is testingA Study With NKT3964 for Adults With Advanced/Metastatic Solid TumorsWho this might be right forSolid TumorAdvanced Solid TumorSolid Tumor, Adult+25 more NiKang Therapeutics, Inc. 150
Post-approval studies (Phase 4)Study completedNCT03930212What this trial is testingProgesterone Supplementation in Threatened AbortionWho this might be right forThreatened AbortionProgesterone Resistance Tanta University 190
Early research (Phase 1)Study completedNCT00031681What this trial is testing7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)Who this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more National Cancer Institute (NCI) 41
Early research (Phase 1)Study completedNCT01197170What this trial is testingHormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome ResistanceWho this might be right forSolid TumorsAdvanced Cancer M.D. Anderson Cancer Center 277
Not applicableLooking for participantsNCT06414720What this trial is testingSalivary microRNA in Endometriosis: Correlation With Response to Progestin TherapyWho this might be right forEndometriosis University of Udine 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07714070What this trial is testingOrlistat Plus Progestin for Fertility-Sparing Treatment of Endometrial Cancer or Atypical HyperplasiaWho this might be right forEndometrial NeoplasmsEndometrial CancerAtypical Endometrial Hyperplasia+1 more Peking University People's Hospital 48
Early research (Phase 1)Ended earlyNCT06264921What this trial is testingA Study With NKT3447 for Adults With Advanced/Metastatic Solid TumorsWho this might be right forSolid TumorSolid Tumor, AdultAdvanced Solid Tumor+26 more NiKang Therapeutics, Inc. 23
Early research (Phase 1)Study completedNCT07173361What this trial is testingProgesterone and Muscle Protein Synthesis in Premenopausal Women (MP4-MPS)Who this might be right forHealthy VolunteersFemaleProgesterone+1 more McMaster University 20
Very early researchStudy completedNCT03356964What this trial is testingStep Down FSH Approach and Late Follicular Phase in Progesterone LevelWho this might be right forProgesterone Resistance ART Fertility Clinics LLC 127
Not applicableUnknownNCT04163380What this trial is testingResistance Training and Sex Hormone Concentrations During the Menstrual CycleWho this might be right forWomen's Health Southern Illinois University Edwardsville 25
Not applicableStudy completedNCT01385280What this trial is testingPilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast CancerWho this might be right forEstrogen Receptor-positive Breast CancerProgesterone Receptor Positive TumorRecurrent Breast Cancer+2 more University of Arizona 13
Not applicableStudy completedNCT03154190What this trial is testingHealth Care Coach Support in Reducing Acute Care Use and Cost in Patients With CancerWho this might be right forAcute Myeloid LeukemiaBrain GlioblastomaEstrogen Receptor Negative+64 more Stanford University 128
Testing effectiveness (Phase 2)Ended earlyNCT04504916What this trial is testingZilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002)Who this might be right forTriple-negative Breast CancerNon-squamous Non-small-cell Lung CancerNSCLC+12 more VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 102
Large-scale testing (Phase 3)Looking for participantsNCT05316935What this trial is testingGnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia PatientsWho this might be right forEndometrial NeoplasmsAtypical Endometrial HyperplasiaProgesterone Resistance Xiaojun Chen 80
Not applicableStudy completedNCT03519776What this trial is testingVariation of Progesterone in IVF CyclesWho this might be right forProgesterone Resistance ART Fertility Clinics LLC 30
Early research (Phase 1)Study completedNCT02152943What this trial is testingEverolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive PatientsWho this might be right forAdvanced Malignant Solid NeoplasmEstrogen Receptor PositiveHER2/Neu Positive+10 more M.D. Anderson Cancer Center 37